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Abstract
Background: It has been postulated that inflammation caused by certain viruses might result in
cancer. Recently, it was shown that childhood lymphoblastic leukemia, breast and ovarian cancers
express an interferon-related signature, providing support for this notion. We have previously
shown that 38% of the sporadic breast cancers contain MMTV-like env gene sequences. To find out
if the presence and expression of MMTV-like sequences correlated with an inflammatory
phenotype, we have compared the expression profile of two sublines of MCF-7 cells, one
containing the MMTV-like sequences (env+), the other one lacking them (env-).
Results: The results indicated that there were 47 differentially expressed genes between the two
sublines. Among 27 upregulated genes in the env+ cells there were 7 interferon-related genes, 5
TNF-connected genes and 2 TGFβ-related genes.
Conclusion: These results suggest that the env+ cells were most likely responding to an infectious
agent, and support the hypothesis that a viral infection may play a role in breast cancer
pathogenesis.
Background
We and others [1-4] have shown that 37 to 41% of spo-
radic breast cancer samples contain MMTV-like env gene
sequences. The sequences are expressed as RNA [5] and as
protein in breast cancers (Melana et al., submitted). They
are absent from the normal breasts of patients with env
positive tumors [6] and are expressed as RNA exclusively
in the cancer cells [7]. The whole proviral structure, desig-
nated human mammary tumor virus (HMTV), which has
95% homology to MMTV, can be detected in two tumors
[8]. Although sequence variations are observed in the C-
terminal of human sag sequences, the cloned human sag
sequences expressed in human B lymphocytes can activate
human T-cells, as can the mouse Sag, indicating that it can
be functional [9]. Moreover, viral particles with the mor-
phological characteristics of betaretroviruses are observed
in primary cultures of human beast cancer [10]. Taken
together, these results suggest that an infectious agent is
present in some human breast cancers.
Chronic inflammation has been implicated in tumor pro-
gression. New evidence suggests that the inflammation
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caused by certain viruses results in cancer [Reviewed in
[11]]. Recently, it was reported that childhood lymphob-
lastic leukemia, as well as breast and ovarian cancers
express an interferon-related signature, but not found in
other human cancers studied [12]. This finding provides
molecular support for the role of inflammation or viral
infection in cancer pathogenesis [12].
The established breast cancer cell line MCF-7 is widely
used in research, and many subclones are available. Some
of the original isolates produce retroviral-like particles
[13]. Furthermore, May and Westerly [14] described the
presence of an MMTV-like 6.6 Kb EcoR1 fragment in some
of the MCF-7 cell lines, which was absent in other breast
cancer lines and in normal tissue.
Continuous passage with subsequent chromosomal
change [15] may have eliminated viral sequences from
some of them. It has been reported that some sublines of
MCF-7 show biological differences [16] and significant
genetic variation in RNA expression [17,18].
We have previously reported that a subline of MCF-7 con-
taining  env  and LTR sequences [19,20] and that it
expressed the env gene as RNA [7], while other sublines
were negative for env gene [[21] and our own results]. To
find out whether the presence of viral sequences is related
to an interferon-related signature, we have compared the
expression profiles of two sublines of MCF-7 [22], one
which contains the MMTV-like env gene sequence (env+)
and one which lacks it (env-).
Results
The presence of the Env protein was investigated in both
sublines. In Fig. 1 the result of the immunoblotting exper-
iment is shown. The HMTV env+ cell line expressed a pro-
tein of a MW of approximately 50 kD which reacted with
mAbP2, a monoclonal antibody against a synthetic pep-
tide derived from human env sequences (Melana et al sub-
mitted). It was absent in the HMTV env- cells. Tubulin was
equally present in both extracts.
The results of the cDNA arrays are shown in Tables 1 and
2. Nineteen genes showed a > 2.5 fold difference in their
adjusted intensity between HMTV env+ and env- cells,
while another eight genes were only expressed in the
HMTV env+ cells (Table 1). Twenty genes were downregu-
lated (Table 2) in HMTV env + cells. Taken together, there
were 47 differentially expressed genes. Among the 27
upregulated genes there were six interferon-inducible
ones: IFI6, TRIM22, IFITM1, IFITM2+IFITM3, IFI27 and
IP-30 and a receptor IFNGR2. In addition, there were five
upregulated genes that have a connection with TNF or are
involved in its signaling, like LTBR, TRAF3, MMP17,
Western blot of MCF-7 cells Figure 1
Western blot of MCF-7 cells. Experimental conditions as described in Materials and Methods. A: MCF-7 (+) cells; B: MCF-7(-) 
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PKN1 and MAPK13. The cytokine TGFβ, and its down-
stream effector early growth response protein 1 (EGR1),
were also upregulated in env+ cells. Twenty genes were
down regulated in HMTV env+ cells.
Discussion
Comparison of the expression profiles of sublines derived
from the same cell line provides an excellent model with
minimal differences. Karyogenetic analysis revealed that
the two sublines have similar complex chromosomal pat-
terns (not shown). The comparison of expression profiles
of MCF-7 env+ and env- cells indicated preferential expres-
sion of interferon-related genes: 26% (7/27) of the up-reg-
ulated genes. These differences may indicate a trend. Einav
et al. [12] have reported that 40% of clinical breast cancer
samples display an interferon-associated signature; 17 out
of 36 (47%) of the upregulated genes. Our results are con-
sistent with, but cannot be directly compared with those
of Einav's for several reasons: we used only one cell line
for analysis, the participation of stroma and surrounding
tissues has been eliminated from our study, and finally,
we used a different set of arrays. Nevertheless, our results
strongly indicate that HMTV env+  MCF-7 cells express
more interferon-related genes than the HMTV env- MCF-7
cells, suggesting that they may be responding to an infec-
tious agent as proposed by Einav et al. [12]. The expres-
sion profile of HMTV env+ cells suggests an increased
potential for cell growth, a fact that may be related to their
more malignant phenotype as has been described in
breast cancer cells associated with HMTV [23,3,24]. It is
remarkable that the alpha 7 and beta 4 integrins were sig-
nificantly down regulated in env+ cells, as has been
reported in a set of finite life-span metastatic breast cancer
cells which were also env+ [25].
Whether the HMTV works as initiator and/or as promoter
of malignant growth is uncertain. Molecular evidence that
HMTV expression is responsible for the increase in inter-
feron-related expression is being sought.
Conclusion
The results clearly indicate that the transcriptional profile
of the cells expressing HMTV sequences is enriched in
genes involved in inflammation process. This finding is
significant because it was obtained comparing cells
derived from the same cell line that have similar genetic
background and minimal expressing differences. This sup-
ports the hypothesis that a viral infection may play a role
in breast cancer pathogenesis.
Table 1: Up-regulated genes in HMTV env+ cells
Acc # Gene symbol Protein/gene Ratio Diff
X02492 IFI6 Interferon-inducible protein 6 12.44 4108
J05633 ITGB5 Integrin beta 5 9.46 3401
X82200 TRIM22 Tripartite motif-containing 22 5.76 1495
L03840 FGFR4 Fibroblast growth factor receptor 4 5.72 1742
J04164 IFITM1 Interferon induced transmembrane protein 1 (9–27) 5.38 6776
M64595 small G protein 4.74 1720
X57351 IFITM2 + IFITM3 interferon induced transmembrane prot 2 (1–8D) + 3 (1–8U) 4.25 1082
X89576 MMP17 matrix metalloproteinase 17 4.20 1647
X52541 EGR1 early growth response protein 1 3.39 1327
L29220 CLK3 CDC-like kinase 3 3.38 1521
X66362 PCTK3 PCTAIRE protein kinase 3 3.34 1368
U33053 PKN1 protein kinase N1 2.85 1075
L04270 LTBR lymphotoxin beta receptor (TNFR superfamily, member3) 2.79 1406
U09579 CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 2.69 6193
U14966 RPL5 60S ribosomal protein L5 2.68 1641
M29039 JUNB jun-B 2.65 1313
M29971 MGMT 6-O-methylguanine-DNA methyltransferase 2.63 1971
M65199 EDN2 endothelin 2 2.58 1535
U57342 MLF2 myeloid leukemia factor 2 2.52 2897
X69398 CD47 CD47 glycoprotein; integrin-associated protein Up 4152
U12255 FCGRT Fc fragment of IgG, receptor, transporter Up 2960
AF004709 MAPK13 mitogen-activated protein kinase 13 Up 2049
X02812 TGFB transforming growth factor, beta 1 Up 1535
U21092 TRAF3 TNF receptor-associated factor 3 Up 1407
U05875 IFNGR2 interferon gamma receptor 2 Up 1372
X67325 IFI27 interferon, alpha-inducible protein 27 Up 1182
J03909 gamma-interferon-inducible protein; IP-30 Up 1076Infectious Agents and Cancer 2006, 1:7 http://www.infectagentscancer.com/content/1/1/7
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Methods
MCF-7 cells were obtained from American Type Culture
Collection (ATCC) and were propagated in vitro as rec-
ommended by the provider and as described in previous
publications (1, 5). To determine whether the viral pro-
tein was expressed in our MCF-7 cells, western blotting
was used. Protein lysates were prepared from approxi-
mately 1 × 107 cells. Equal amounts of protein from each
sample were loaded onto an SDS-PAGE-10% polyacryla-
mide gel, followed by transfer to PVDF membranes. West-
ern blot analysis was performed using mAbP2 (a
monoclonal antibody against a peptide of the Env pro-
tein), and mAb-tubulin as primary antibodies (Sigma
Aldrich). Proteins were visualized using horseradish per-
oxidase-labeled sheep anti-mouse IgG (GE Healthcare
Bio-Sciences Corp.) as a secondary antibody followed by
enhanced chemiluminescence (GE Healthcare Bio-Sci-
ences Corp.).
The expression profile was studied using the Atlas Human
Cancer 1.2 cDNA expression array; a nylon membrane
printed with 200–600 bp long fragments of 1176 charac-
terized genes involved in cancer, 9 housekeeping genes
and 6 negative controls (Clontech, CA). These conditions
were described in detail in a previous publication [25].
Briefly, RNA was extracted and labeled with Atlas pure
total RNA labeling system and hybridized to an Atlas
Human Cancer 1.2 cDNA expression array (Clontech, CA)
according to the manufacturer's instructions. Both cell
sublines were probed twice in separate assays, and the
accuracy of each duplicate was assessed by Pearson's cor-
relation coefficient based on the adjusted intensity of all
genes spotted on the membrane.
Hybridizations with 30 μg of total RNA were performed
according to the manufacturer instructions. The hybrid-
ized membranes were exposed onto a phosphorimager
screen and were read using a phosphorimager reader
(Molecular Dynamics). The scanned images were aligned
and analyzed using AtlasImage 2.01 software (Clontech).
When averaging or comparing samples, the adjusted
intensity signal was normalized using the global normali-
zation mode featured in the software. We reported only
those genes whose ratios of differential expression were
2.5-fold or more, or genes that were undefined for one
type of sample, but were detected on the other. (Unde-
fined genes are those whose intensity were below the sig-
nal threshold) In the later event, when we lack a
numerical value for the ratio, it was defined as being "up"
or "down". Furthermore, for each gene we stated the dif-
ference (diff) in adjusted normalized intensity between
the two cell lines.
Accession number (Acc#), gene symbol and protein or
gene name are according to GeneBank.
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Table 2: Down-regulated genes in HMTV env+ cells
Acc # Gene symbol Protein/gene Ratio Diff
U02687 FLT3 fms-related tyrosine kinase 3 -6.20 -2143
X74295 IGA7B integrin alpha 7B -5.13 -2249
X53587 ITGB4 integrin beta 4 -4.80 -2384
M34671 CD59 CD59 molecule, complement regulatory protein -3.60 -2551
L25081 RHOC ras homolog gene family, member C -3.59 -2341
U89278 PHC2 polyhomeotic-like 2 -3.53 -1250
X16277 ODC1 ornithine decarboxylase 1 -2.87 -1295
AF029670 RAD51C RAD51 homolog C -2.61 -1713
M20430 HLA-DRB1 MHC class II HLA-DR-beta Down -4288
J04111 JUN c-jun proto-oncogene; transcription factor AP-1 Down -1745
U70310 FANCG DNA repair protein XRCC9 Down -1514
M59911 ITGA3 integrin alpha 3 Down -1393
M97934 STAT2 signal transducer and activator of transcription 2 Down -1248
L38518 SHH sonic hedgehog Down -1183
X51521 VIL2 ezrin; villin 2 Down -1177
L07515 CBX5 chromobox homolog 5; heterochromatin protein homolog 1 (HP1) Down -1153
M15400 RB1 retinoblastoma 1 Down -1109
M54995 PPBP pro-platelet basic protein Down -1100
X54199 GART trifunctional purine biosynthetic protein adenosine 3 Down -1092
U47686 STAT5 A +B signal transducer and activator of transcription 5 A+B Down -1072Publish with BioMed Central    and   every 
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